Anthrax Vaccines Market
Anthrax Vaccines Market Scope: Industry
Analysis, Market Size, Growth, Trends till 2030
Download Anthrax Vaccines Market Report
Anthrax Vaccine Market Size and Growth
The anthrax vaccine market has been witnessing steady growth due to increasing concerns about bioterrorism and the need for better preventive measures in regions prone to anthrax outbreaks. In 2023, the market size was valued at around USD 600 million, and it is expected to grow at a compound annual growth rate (CAGR) of approximately 8% from 2024 to 2030. The rise in government initiatives for biosecurity, military demand, and growing livestock vaccinations contribute to the expansion of the market.
Companies Covered : (Covid-19 Impact Covered)
o Emergent BioSolutions Inc
o Merck & Co.
o Pfizer Inc.
o Bharat Biotech
o GlaxoSmithKline
Companies such as Emergent BioSolutions, Merck, Altimmune, and Bharat Biotech are expected to lead advancements in vaccine technologies. As governments and organizations prioritize preventive healthcare measures, the demand for vaccines across both human and veterinary applications will sustain the market’s upward trajectory.
Anthrax Vaccine Market Segmentation
By Application
✓ Human Vaccination
✓ Veterinary Vaccination
By Product
• Cell-Free Anthrax Vaccines
• Live Attenuated Anthrax Vaccines
Anthrax Vaccine Market Growth 2024-2030
$ X Billion USD
Market Size (USD)
